Amid the surging novel coronavirus cases in India, the country’s ‘first’ indigenous COVID-19 vaccine COVAXIN has got the nod for human clinical trials from the Drug Controller General of India (DGCI). The drug has been developed by Hyderabad-based Bharat Biotech.…

A potential COVID-19 vaccine, the first to be developed in India, has been given DCGI (Drug Controller General of India) approval for Phase I and II human clinical trials that are scheduled to start across the country in July. Developed…